Details for 2019858883

Up to date per 02.04.2026

Actions

Title / Product Name

KOMBINATION VON DASATINIB UND ADAGRASIB ZUR BEHANDLUNG VON NICHT-KLEINZELLIGEM LUNGENKARZINOM

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019858883

EP Publication Number

3849534

E-Number

1772288

Language

PCT Number

US19050224

Publication Date

21.07.2021 A

05.03.2025 B1

Registration Date

05.03.2025

AT Publication Date

15.03.2025

Application Date

09.09.2019

Registration Number

Priorities

10.09.2018

201862729169 P

IPC

A61K 31/5025 20060101AFI20220516BHEP

Maximum Duration of Protection

09.09.2039

Owner

Mirati Therapeutics, Inc.Route 206 and Province Line Road Princeton, New Jersey 08543US

Representative

No representatives present

Inventor

ENGSTROM, Lars, Daniel7974 Amargosa Dr. Carlsbad, CA 92009US

ARANDA, Ruth, Wei10797 San Diego Mission Rd. Unit 311 San Diego, CA 92108US

OLSON, Peter4763 Robbins St. San Diego, CA 92122US

CHRISTENSEN, James, Gail4276 Kenwood ct. San Diego, CA 92130US

Information about Fees